22 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Medications: ... #Pharmacology # ... Neuropathic #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
- Transdermal Medications ... #Pharmacology # ... Transdermal #Topical #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Pharmacology # ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... #Pharmacology # ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... #Pharmacology # ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Procedural Sedation and Analgesia Medications 

#Management #Pain #Pharmacology #PSA
and Analgesia Medications ... #Pharmacology # ... Sedation #Analgesia #Medications ... #Doses #Dosing ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
and Nebulized Medications ... #Pharmacology # ... Intranasal #Nebulized #Medications ... #Doses #Dosing ... #Table #PAMI
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
form and consider using ... than stopping medication ... #Metformin #Indications ... #Titration #Pharmacology ... #Diabetes #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Guide Classes ... #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology # ... comparison #table
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid ... - Indications and ... of Excretion: Urine ... diarrhea & abdominal pain ... #Indications #Pharmacology